Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Dr. Margaret Shipp received her Doctor of Medicine from Washington University School of Medicine and completed an internal medicine internship and residency at Barnes Hospital/Washington University. Thereafter, she completed a fellowship in Medical Oncology at DFCI and subsequently joined the faculty.
Dr. Shipp is currently the Chief of the Division of Hematologic Neoplasia at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. Her clinical and laboratory research focuses on the clinical and molecular heterogeneity of the large B-cell lymphomas (LBCLs) and Hodgkin lymphoma. Dr. Shipp coordinated the development of the International Prognostic Index which is used worldwide to individualize treatment approaches to LBCLs and many other lymphoid malignancies. More recently, she has led efforts to define molecular signatures of LBCLs and Hodgkin lymphomas, identify biologically distinct subsets of these diseases, and characterize associated rational treatment targets including modulators of the host anti-tumor immune response.
Dr. Shipp previously served on the Scientific Advisory Committee of the International Conference on Malignant Lymphoma and gave the first Gianni Bonadonna Memorial Lecture. She is member of the American Society for Clinical Investigation, the Association of American Physicians and the National Academy of Medicine and a Fellow of the American Association of Cancer Research Academy.
Disclosure information not submitted.
Molecular Characterization and Classification of Aggressive B-Cell Lymphomas
Saturday, November 18, 2023
2:30 PM - 3:15 PM MST